Neuromuscular choristoma (NMC) is a rare peripheral nerve lesion in which mature skeletal muscle fibers lie within the nerve and its fascicles. Given limited follow-up, its natural history is poorly understood. The occurrence of aggressive fibromatosis in one of the authors' patients and its occurrence in reported cases suggests an etiological relationship between the 2 lesions. This study attempts to explain the association and its frequency.
All cases of NMCs seen in consultation or treated at the Mayo Clinic were identified. Demographic and clinical data were reviewed in cases with coexistent aggressive fibromatosis. Pathology and neuroimaging studies were reexamined. In addition, an extensive literature review was performed to explore the association of NMC with aggressive fibromatosis, with special attention given to pathological and imaging characteristics and the development of aggressive fibromatosis.
The authors identified 10 patients with a diagnosis of NMC who were treated at the Mayo Clinic between 1992 and 2010. Four of 5 with adequate follow-up had developed a definite or suspected aggressive fibromatosis. A review of the initial pathological specimens in these cases revealed no evidence of fibromatosis, but all of the lesions exhibited accompanying hypocellular collagenous tissue. On MR images, all cases showed areas of low signal intensity, which significantly differed from muscle, nerve, and NMC components. On available serial MR imaging studies, aggressive fibromatosis seemed to originate in such lower-intensity regions. In the 18 previously reported cases of NMC, 5 patients developed recurrent masses diagnosed as either definite (2 cases) or possible (3 cases) fibromatosis. Review of the published imaging studies in these cases suggests the presence of lower intensity areas similar to those observed in the 10 patients treated at the Mayo Clinic.
This study confirms that the development of aggressive fibromatosis in patients with NMC has been underreported. A direct relationship between the NMC and the development of aggressive fibromatosis is suggested by pathological and neuroimaging evidence.
Abbreviation used in this paper: NMC = neuromuscular choristoma.
Address correspondence to: Robert J. Spinner, M.D., Mayo Clinic, 200 First Street SW, Gonda 8-214S, Rochester, Minnesota 55905. email: firstname.lastname@example.org.Please include this information when citing this paper: published online August 5, 2011; DOI: 10.3171/2011.6.JNS102171.
CunniffeGFernándezJAlonsoTBalaguerODinaresCHuguetP: Thyroid orbitopathy obscuring the diagnosis of a rare neuromuscular hamartoma of the superior rectus muscle in an adult. Orbit29:168–1702010
CunniffeG, FernándezJ, AlonsoT, BalaguerO, DinaresC, HuguetP, : Thyroid orbitopathy obscuring the diagnosis of a rare neuromuscular hamartoma of the superior rectus muscle in an adult. 29:168–170, 2010)| false
Van DorpeJSciotRDe VosRUyttebroeckAStasMVan DammeB: Neuromuscular choristoma (hamartoma) with smooth and striated muscle component: case report with immunohistochemical and ultrastructural analysis. Am J Surg Pathol21:1090–10951997
Van DorpeJ, SciotR, De VosR, UyttebroeckA, StasM, Van DammeB: Neuromuscular choristoma (hamartoma) with smooth and striated muscle component: case report with immunohistochemical and ultrastructural analysis. 21:1090–1095, 1997)| false
ZannolliRMostardiniRPucciLSorrentinoLBiagioliMPerottiR: Corpus callosum agenesis, multiple cysts, skin defects, and subtle ocular abnormalities with a de novo mutation [45,XX,der(5), t(5;14) (pter;q11.2)]. Am J Med Genet102:29–352001
ZannolliR, MostardiniR, PucciL, SorrentinoL, BiagioliM, PerottiR, : Corpus callosum agenesis, multiple cysts, skin defects, and subtle ocular abnormalities with a de novo mutation [45,XX,der(5), t(5;14) (pter;q11.2)]. 102:29–35, 2001)| false